These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32641979)

  • 81. A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis.
    Chen Y; Zhou Y; Han F; Zhao Y; Tu M; Wang Y; Huang C; Fan S; Chen P; Yao X; Guan L; Yu AM; Gonzalez FJ; Huang M; Bi H
    Theranostics; 2020; 10(16):7193-7210. PubMed ID: 32641987
    [No Abstract]   [Full Text] [Related]  

  • 82. Systemic triglyceride storage disease with normal carnitine: a putative defect in long-chain fatty acid metabolism.
    Ibayashi H; Ideguchi H; Harada N; Ishimoto S; Goto I
    J Neurol Sci; 1988 Jun; 85(2):149-59. PubMed ID: 3385431
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study.
    Budczies J; Denkert C; Müller BM; Brockmöller SF; Klauschen F; Györffy B; Dietel M; Richter-Ehrenstein C; Marten U; Salek RM; Griffin JL; Hilvo M; Orešič M; Wohlgemuth G; Fiehn O
    BMC Genomics; 2012 Jul; 13():334. PubMed ID: 22823888
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers.
    Aiderus A; Black MA; Dunbier AK
    BMC Cancer; 2018 Aug; 18(1):805. PubMed ID: 30092766
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Mass Spectrometry Imaging of Lumpectomy Specimens Deciphers Diacylglycerols as Potent Biomarkers for the Diagnosis of Breast Cancer.
    Mondal S; Sthanikam Y; Kumar A; Nandy A; Chattopadhyay S; Koner D; Rukmangadha N; Narendra H; Banerjee S
    Anal Chem; 2023 May; 95(20):8054-8062. PubMed ID: 37167069
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans.
    Manna SK; Tanaka N; Krausz KW; Haznadar M; Xue X; Matsubara T; Bowman ED; Fearon ER; Harris CC; Shah YM; Gonzalez FJ
    Gastroenterology; 2014 May; 146(5):1313-24. PubMed ID: 24440673
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy.
    Schaefer J; Jackson S; Taroni F; Swift P; Turnbull DM
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):169-76. PubMed ID: 9048718
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Spatially resolved metabolomics combined with multicellular tumor spheroids to discover cancer tissue relevant metabolic signatures.
    Zang Q; Sun C; Chu X; Li L; Gan W; Zhao Z; Song Y; He J; Zhang R; Abliz Z
    Anal Chim Acta; 2021 Apr; 1155():338342. PubMed ID: 33766316
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features.
    Lehmann D; Motlagh L; Robaa D; Zierz S
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054946
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Quantitative analysis of amino acids and acylcarnitines combined with untargeted metabolomics using ultra-high performance liquid chromatography and quadrupole time-of-flight mass spectrometry.
    Roy C; Tremblay PY; Bienvenu JF; Ayotte P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():40-9. PubMed ID: 27240302
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort.
    Lécuyer L; Dalle C; Lyan B; Demidem A; Rossary A; Vasson MP; Petera M; Lagree M; Ferreira T; Centeno D; Galan P; Hercberg S; Deschasaux M; Partula V; Srour B; Latino-Martel P; Kesse-Guyot E; Druesne-Pecollo N; Durand S; Pujos-Guillot E; Touvier M
    Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1300-1307. PubMed ID: 31164347
    [TBL] [Abstract][Full Text] [Related]  

  • 92. An integrative approach based on GC-qMS and NMR metabolomics data as a comprehensive strategy to search potential breast cancer biomarkers.
    Silva CL; Perestrelo R; Capelinha F; Tomás H; Câmara JS
    Metabolomics; 2021 Aug; 17(8):72. PubMed ID: 34389918
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A graphical data processing pipeline for mass spectrometry imaging-based spatially resolved metabolomics on tumor heterogeneity.
    Huang L; Mao X; Sun C; Luo Z; Song X; Li X; Zhang R; Lv Y; Chen J; He J; Abliz Z
    Anal Chim Acta; 2019 Oct; 1077():183-190. PubMed ID: 31307708
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Spatially resolved visualization of reprogrammed metabolism in hepatocellular carcinoma by mass spectrometry imaging.
    Ma B; Zhang Y; Ma J; Chen X; Sun C; Qin C
    Cancer Cell Int; 2023 Aug; 23(1):177. PubMed ID: 37620880
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Integrative metabolomic profiling reveals aberrations in myometrium associated with adenomyosis: a pilot study.
    Song W; Zhang Z; Jiang Y; Cao Y; Zhang B; Wang Y; Shi H; Zhu L
    Reprod Biol Endocrinol; 2022 Mar; 20(1):49. PubMed ID: 35264202
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
    Sun J; Ding J; Shen Q; Wang X; Wang M; Huang Y; Zhang X; Zhu H; Zhang F; Wu D; Peng M; Zhang Z; Yuan Y; Li W; She ZG; Zhang XJ; Li H; Zhang P; Huang Z
    J Hepatol; 2023 Mar; 78(3):627-642. PubMed ID: 36462680
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Metabolomics reveals that carnitine palmitoyltransferase-1 is a novel target for oxidative inactivation in human cells.
    Setoyama D; Fujimura Y; Miura D
    Genes Cells; 2013 Dec; 18(12):1107-19. PubMed ID: 24118240
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Metabolomics patterns of breast cancer tumors using mass spectrometry imaging.
    Theriault RL; Kaufmann M; Ren KYM; Varma S; Ellis RE
    Int J Comput Assist Radiol Surg; 2021 Jul; 16(7):1089-1099. PubMed ID: 34053013
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences.
    Valentino A; Calarco A; Di Salle A; Finicelli M; Crispi S; Calogero RA; Riccardo F; Sciarra A; Gentilucci A; Galderisi U; Margarucci S; Peluso G
    Oncogene; 2017 Oct; 36(43):6030-6040. PubMed ID: 28671672
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesis.
    Yao M; Zhou P; Qin YY; Wang L; Yao DF
    World J Gastroenterol; 2023 Mar; 29(12):1765-1778. PubMed ID: 37032731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.